Literature DB >> 12202152

Oxidative stress is involved in the heat stress-induced downregulation of TCR zeta chain expression and TCR/CD3-mediated [Ca(2+)](i) response in human T-lymphocytes.

Madhusoodana P Nambiar1, Carolyn U Fisher, Edith J Enyedy, Vishal G Warke, Anil Kumar, George C Tsokos.   

Abstract

Exposure of human T-lymphocytes to heat downregulates TCR zeta chain expression and inhibits (TCR)/CD3-mediated production of inositol triphosphate and [Ca(2+)](i) signaling. Here we investigated whether oxidative stress is involved in the heat-induced downregulation of TCR/CD3-mediated signaling. To this end, we have studied the effect of a thiol antioxidant, N-acetyl-L-cysteine (NAC), and a non-thiol antioxidant, allopurinol, on heat-induced downregulation of TCR/CD3-mediated signaling. We found that preincubation of cells with 10mM NAC significantly reversed the downregulation of TCR/CD3-mediated [Ca(2+)](i) response and restored the suppression of TCR zeta chain protein expression as well as prevented its increased membrane distribution in heat-treated cells. NAC also reversed the downregulation of TCR zeta chain mRNA expression and the active 94kDa TCR zeta chain transcription factor, Elf-1, in heat-treated cells. Consistent with the increase in the TCR zeta chain, preincubation with NAC increased the levels of antigen receptor-induced tyrosine phosphorylation of several cytosolic proteins. Finally, treatment with NAC was able to reverse the suppression of IL-2 production in heat-treated cells. Inactive analog, N-acetylserine, failed to reverse the heat-induced downregulation of TCR/CD3-mediated signaling. Allopurinol, another potent non-thiol antioxidant, also restored the TCR/CD3-mediated [Ca(2+)](i) response in heat-treated cells. These results demonstrate that antioxidants restore the expression of TCR zeta chain and reverse the TCR/CD3-mediated signaling abnormalities associated with heat stress and suggest that heat shock-induced oxidative stress is a mediator of the heat-induced biochemical damage that leads to downregulation of signaling in human T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202152     DOI: 10.1016/s0008-8749(02)00006-0

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

2.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

3.  Effect of environmental hyperthermia on gastrin, somatostatin and motilin in rat ulcerated antral mucosa.

Authors:  Feng-Peng Sun; Yu-Gang Song
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

4.  Reduced oxidative stress promotes NF-kappaB-mediated neuroprotective gene expression after transient focal cerebral ischemia: lymphocytotrophic cytokines and antiapoptotic factors.

Authors:  Yun Seon Song; Yong-Sun Lee; Purnima Narasimhan; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2006-07-26       Impact factor: 6.200

Review 5.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 6.  T-cell and B-cell signaling biomarkers and treatment targets in lupus.

Authors:  Andras Perl; David R Fernandez; Tiffany Telarico; Edward Doherty; Lisa Francis; Paul E Phillips
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 7.  Oxidative stress in the pathology and treatment of systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2013-10-08       Impact factor: 20.543

8.  Effect of high-dose intravenous vitamin C on inflammation in cancer patients.

Authors:  Nina Mikirova; Joseph Casciari; Andrea Rogers; Paul Taylor
Journal:  J Transl Med       Date:  2012-09-11       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.